| 24107/34351 | US=84 / Biol/Mol Bhowmick NA. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: TGF-B signaling in fibroblastic cells and oncogenesis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 185-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; CELULAS ESTROMAIS; MESENQUIMA; PANCA; PROSTATA; TUMORIGENESE |
| 24108/34351 | US=84 / Biol/Mol Kim TA, Kim SJ. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of TGF-B-induced apoptosis in cancer cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 199-211. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24109/34351 | US=84 / Biol/Mol Gold LI, Lecanda J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of cell cycle regulation by TGF-B disabled in cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 213-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. P27KIP1; CKS1; SKP2; CANCRO ENDOMETRIAL; UBIQUITINA-PROTEASSOMA |
| 24110/34351 | US=84 / Biol/Mol Band A, Laiho M. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: transforming growth factor-B in cancer therapy. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 243-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-BETA; SMAD; TRANSDUCAO DE SINAL; SNON; PROTEASSOMA; UBIQUITINA; SUMO; DEGRADACAO |
| 24111/34351 | US=84 / Biol/Mol Thuault S, Valcourt U, Kowanetz M, Moustakas A. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: TGF-B and smad signaling in transcriptome reprogramming during EMT. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 259-73. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ADERENTES JUNCAO; EMT; METASTASE; POLARIDADE; JUNCAO APERTADA |
| 24112/34351 | US=84 / Biol/Mol Stuelten CH, Roberts AB, Stetler-Stevenson WG. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: functional interactions between MMPs and TGF-B in normal and tumor tissue. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 275-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; MMP; TUMOR; INTERACAO ESTROMA TUMORAL; SINALIZACAO CELULAR |
| 24113/34351 | US=84 / Biol/Mol Liu IM, Schilling SH, Wang XF. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: Cooperation between TGF-B and Wnt pathway components in regulating mesenchymal stem cell function. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 293-303. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CELULAS-TRONCO MESENQUIMAIS; SMAD3; B-CATENINA; CROSSTALK; PROLIFERACAO; DIFERENCIACAO |
| 24114/34351 | US=64 / Câncer Dhodapkar MV. Immunobiology and immunotherapy of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4. IMUNOLOBIOLOGIA DO MIELOMA MULTIPLO; IMUNOTERAPIA DO MIELOMA MULTIPLO |
| 24115/34351 | US=84 / Biol/Mol Glick A, Bae DS, Liu X, Vijayachandra K. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: interaction of oncogenic ras and TGFB1 signaling in cancer: lessons from the multistage skin carcinogenesis model. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 305-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGFB1; ONCOGENE RAS; PELE; QUERATINOCITOS; VARIOS ESTAGIOS DA CARCINOGENESE; CANCER DE PELE |
| 24116/34351 | US=84 / Biol/Mol Souchelnytskyi S. TGF-B superfamily members in normal and tumor biology: proteomics analysis of TGFB superfamily members. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 319-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. PROTEOMICA; SINALIZACAO; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; PROTEINAS MORFOGENETICAS DO OSSO; SMAD |
| 24117/34351 | US=84 / Biol/Mol MacLaughlin DT, Donahoe PK. TGF-B superfamily members in normal and tumor biology: mullerian inhibiting substance: a potencial nontoxic, naturally occurring therapeutic agent for certain human cancers. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 333-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24118/34351 | US=84 / Biol/Mol Hayashida T, Gupta V, Thiagalingam S, Maheswaran S. TGF-B superfamily members in normal and tumor biology: activins, inhibins, and bone morphogenetic proteins as modulators and biomarkers of prostate cancer progression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 355-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CANCER DE PROSTATA; ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 24119/34351 | US=84 / Biol/Mol Berberian G, Malhotra D, Langenfeld JE. TGF-B superfamily members in normal and tumor biology: bone morphogenic proteins and angiogenesis in developing tumors. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 373-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 24120/34351 | US=84 / Biol/Mol Leader JE, Frontelo MP, Lechleider RJ. TGF-B superfamily members in normal and tumor biology: histone methyltransferase and smad interactions in BMP signaling. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 383-93. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. HISTONA METILTRANSFERASE; SMAD; BMP; RECEPTORES DE CELULAS DE SUPERFICIE; FAMILIA SUV39H; CROMATINA |
| 24121/34351 | US=84 / Biol/Mol Fonsatti E, Maio M. TGF-B superfamily members in normal and tumor biology: endoglin (CD105): a strong candidate for immunologic targeting of tumor neovasculature in human malignancies. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 395-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ENDOGLINA; CD105; ANGIOGENESE; CARCINOGENESE; CELULAS ENDOTELIAIS; VASCULAR ALVO |
| 24122/34351 | US=84 / Biol/Mol Risbridger GP, Butler C. TGF-B superfamily members in normal and tumor biology: activins and cancer progression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 411-23. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. INIBIDORES; ACTIVINA; TUMORIGENESE; X SUBUNIDADE; SUBUNIDADE BA; METASTASE; ANGIOGENESE; SUPRESSAO IMUNITARIA |
| 24123/34351 | US=84 / Biol/Mol Mazerbourg S. TGF-B superfamily members in normal and tumor biology: bone morphogenetic proteins/growth differentiation factors and smad activation in ovarian granulosa cells and carcinoma. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 425-50. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; BMP; GDF; SMAD; TGF-B RECEPTOR; CANCER NO OVARIO; OVARIO; CELULAS DA GRANULOSA; VIA DE SINALIZACAO |
| 24124/34351 | US=84 / Biol/Mol López-Casillas F, Vilchis-Landeros MM, Esparza-López J, Ponce-Castañeda MV, Velasco-Loyden NG, Juárez P, Montiel JL, Mendoza V. TGF-B superfamily members in normal and tumor biology: regulation of the transforming growth factor-B superfamily by betaglycan. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 451-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B TIPO III RECEPTOR; TGF-B; TGF-B INIBIDORES; TUBERCULOSE; BETAGLICAM; BETAGLICAM NULOS RATOS; ECOTODOMAIN DERRAMAMENTO; DESENVOLVIMENTO CABECA; INIBINA; NEFROPATIAS; XENOGRAFS TUMORAIS |
| 24125/34351 | US=84 / Biol/Mol Yanagita M. TGF-B superfamily members in normal and tumor biology: uterine sensitization associated gene-1: a bone morphogenetic protein antagonist with a role in kidney. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 463-73. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24126/34351 | US=84 / Biol/Mol Zhao Y, Hei TK. TGF-B superfamily members in normal and tumor biology: role of betaig-h3 gene in carcinogenesis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 475-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. BETAIG-H3; CARCINOGENESE; DISTROFIAS DE CORNEA; METILACAO; PROLIFERACAO; APOPTOSE; ANTITUMORAL |